Repros announce completion of Phase II enrollment in Proellex trial « Nuclear Receptor News

Pages
- About NuclearReceptorCentral
Categories
- Nuclear Receptor (60)
- Uncategorized (23)
Archives

Repros announce completion of Phase II enrollment in Proellex trial

Posted on August 19, 2008 by crimsoncanary

Repros Therapeutics have announced that they now have sufficient patients currently enrolled to provide for adequate power calculations for the Phase III endometriosis trials.

Filed under: Uncategorized | Tagged: Nuclear Receptor, Phase II, Proellex, Progenta, Progesterone, Repros, Repros Therapeutics

« Leo submit NDA/MAA for Xamiol gel FDA Panel Endorse Pfizers Fablyn but with concerns »

Leave a Reply